Emerging Tuberculosis Among Patients with Previous COVID-19

Basit Öğe Kaydı
dc.authoridTanriverdi, Elif Seren/0000-0002-0449-0356
dc.authoridOtlu, Baris/0000-0002-6220-0521
dc.authoridYAKUPOGULLARI, YUSUF/0000-0002-5545-3467
dc.authorwosidTanriverdi, Elif Seren/ABE-4472-2021
dc.authorwosidYAKUPOGULLARI, YUSUF/F-3966-2011
dc.contributor.authorYakupogullari, Yusuf
dc.contributor.authorTanriverdi, Elif Seren
dc.contributor.authorErmis, Hilal
dc.contributor.authorOtlu, Baris
dc.date.accessioned2024-08-04T20:11:41Z
dc.date.available2024-08-04T20:11:41Z
dc.date.issued2022
dc.departmentİnönü Üniversitesien_US
dc.description.abstractCOVID-19 patients have a higher incidence of opportunistic infections, but there is little information on tuberculosis (TB). In this study, it was aimed to determine any possible contribution of COVID-19 in TB emergence among patients diagnosed with TB during the pandemic. A retrospective screening of the regional TB laboratory's records identified TB patients diagnosed in the Malatya region between April 1, 2020, and December 31, 2021. Medical data of TB patients with a prior COVID-19 were evaluated. During the study period, 171 TB patients were diagnosed in the region, with 26 also infected with SARS-CoV-2. Patients' histories revealed that 10 (38.5%) of these 26 patients developed TB symptoms in a median 68.5 days after COVID-19. Four patients had one-week to two-month corticosteroid treatment due to severe COVID-19, and one had a hematological malignancy history. However, the remaining five patients had no significant predisposing factor for TB relapse. Four out of 10 patients were free of any finding for active TB before COVID-19. Severe COVID-19 may have some obvious implications for TB reactivation, but there was no conclusive evidence of such an effect in mild to moderate COVID-19. Nonetheless, inquiring about COVID-19 histories from TB patients in large-scale studies may provide high-quality evidence about the interactions between the two pathogens.en_US
dc.identifier.doi10.5578/flora.20229616
dc.identifier.endpage663en_US
dc.identifier.issn1300-932X
dc.identifier.issue4en_US
dc.identifier.startpage659en_US
dc.identifier.trdizinid1168569en_US
dc.identifier.urihttps://doi.org/10.5578/flora.20229616
dc.identifier.urihttps://search.trdizin.gov.tr/yayin/detay/1168569
dc.identifier.urihttps://hdl.handle.net/11616/92913
dc.identifier.volume27en_US
dc.identifier.wosWOS:000926400900018en_US
dc.identifier.wosqualityN/Aen_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakTR-Dizinen_US
dc.language.isoenen_US
dc.publisherBilimsel Tip Yayinevien_US
dc.relation.ispartofFlora Infeksiyon Hastaliklari Ve Klinik Mikrobiyoloji Dergisien_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectCOVID-19en_US
dc.subjectSARS-CoV-2 pandemicen_US
dc.subjectTuberculosisen_US
dc.subjectTuberculosis reactivationen_US
dc.titleEmerging Tuberculosis Among Patients with Previous COVID-19en_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
TR-Dizin İndeksli Yayınlar Koleksiyonu